Jefferies calls FormFactor pullback a buying opportunity, shares rise 8%

Jefferies calls FormFactor pullback a buying opportunity, shares rise 8%

Jefferies calls FormFactor pullback a buying opportunity, shares rise 8%
US Labor Secretary Keith E. Sonderling speaks, flanked by Attorney General Todd Blanche and US Vice President JD Vance as they make an H-1B fraud announcement during a press conference on anti-fraud initiatives in the Eisenhower Executive Office Building on the White House campus in Washington, D.C., US, October 8, 2026. Nathan Howard | Reuters…
Wikimedia Commons/Benoît Prieur Third Street Promenade in Santa Monica The world’s best athletes aren’t the only ones preparing for the 2028 Olympic and Paralympic Games. The Los Angeles real estate community is also gearing up as global brands, national sponsors and international delegations quietly shop for storefronts nearly two years before the opening ceremony. Los…
Kalyan Jewellers shares surged 15% in two sessions, touching a 52-week intraday high of Rs 702 on Thursday, after brokerages raised their price targets following a strong Q2 performance and an upbeat festive season outlook. Jefferies increased its target price to Rs 900 from Rs 830 and retained a Buy rating. JM Financial raised its…
WOODRIDGE, Ill., Aug. 14, 2026 /PRNewswire/ — Mahoney Environmental today announced that Laura Nortamo will join the company as Vice President, Finance, effective September 1, 2026. Nortamo will also join Mahoney’s Leadership Team and will report to Dave Kimball, President and CEO. She succeeds Teija Pajamo. “Laura brings a rare combination of financial rigor, operational insight,…
Key insight: As regulators rewrite the rules for anti-money-laundering compliance, they have an opportunity to create standards that will actually prevent financial crime rather than just documenting suspicious activity. What’s at stake: Filing a suspicious activity report isn’t the same as stopping a fraudulent transaction or recouping the money, especially on blockchain rails, where settlement…
IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples collected from UK Biobank participants using Ultima Genomics’ UG200™ Sequencing Platform and the BD Rhapsody™ Single-Cell Platform from Waters Corporation Ultima’s technology continues to support the addition of new omics data layers for UK Biobank and foundational dataset generation…